Prospect Capital (PSEC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Dec, 2025Executive summary
Annual meeting held on December 16, 2025, with proposals detailed in the definitive proxy statement.
Meeting adjourned to January 8, 2026, to allow more time for soliciting votes on the second proposal.
Prospect Capital focuses on lending to and investing in middle market privately-held companies, aiming for current income and long-term capital appreciation.
Forward-looking statements are subject to significant uncertainties and are not guarantees of future performance.
Voting matters and shareholder proposals
Multiple proposals were considered at the annual meeting, with specific details available in the proxy statement.
Adjournment of the meeting was specifically to solicit additional votes for the second proposal.
Shareholder rights and capital structure
As of September 17, 2025, there were over 465 million shares of common stock and various series of preferred stock outstanding, each with voting rights.
Each share of common and preferred stock is entitled to one vote on relevant matters at the annual meeting.
Latest events from Prospect Capital
- Proposal seeks renewed authority to sell common stock below NAV, with Board support and dilution risks.PSEC
Proxy Filing11 Mar 2026 - Shareholders are asked to approve limited sales of stock below net asset value for the next year.PSEC
Proxy Filing11 Mar 2026 - Robust middle-market lender with strong returns, low risk, and disciplined financial management.PSEC
Investor presentation2 Mar 2026 - Shareholders are asked to renew approval for below-NAV stock sales, capped at 25% per sale.PSEC
Proxy Filing27 Feb 2026 - Net investment income was $91M, NAV per share $6.21, and first lien loan exposure increased.PSEC
Q2 202610 Feb 2026 - Net investment income was $102.9M, NAV $8.74, and the 86th straight dividend was declared.PSEC
Q4 202422 Jan 2026 - Net investment income fell as NAV declined and the portfolio shifted to first-lien loans.PSEC
Q1 202515 Jan 2026 - Annual meeting adjourned to January 15, 2026, to solicit more votes on key proposals.PSEC
Proxy Filing8 Jan 2026 - NII was $86.4M, NAV per share $7.84, with strong liquidity and low non-accruals at 0.4%.PSEC
Q2 202523 Dec 2025